Blu Wireless have been showcasing their new 360° Tactical Vehicle Node, which enables scalable tactical connectivity between vehicles. In contrast to commercial networks, tactical 5G military networks necessitate systems which are standalone, secure, can be easily interfaced to existing tactical equipment and are resistant to single point of failure. Blu Wireless is a firm that … Continued
Interview with Richard Moore – Co Head of Investments – Calculus Capital Calculus Capital has over 20 years’ experience investing in UK growth companies. Calculus works in partnership with investee companies, usually taking a seat on the board and providing advice on a strategic level – with the aim of realising the full potential of … Continued
Important note: Past performance is not indicative of future performance. Tax benefits depend on the individual circumstances of each investor and may be subject to change in the future. Calculus portfolio company, CloudTrade, has been acquired by Advanced, a leading provider of business software, delivering a 4x return to Calculus investors in just over 3 … Continued
Created by Calculus portfolio company Wonderhood Studios, the advert, “Set yourself free”, launches Starling’s new brand platform “Here to change”. It debuts on Channel 4 and Sky channels, with airings during shows including Gogglebox. Wonderhood’s first campaign for Starling Bank, aimed at new businesses, aired in February 2020.
Essentia’s software uses data analytics and behavioural finance research to help allocators and active asset managers make better decisions and improve their returns. Essentia expects to expand headcount and accelerate research and development following an investment by Northern Trust. Northern Trust (Nasdaq: NTRS) has reached an agreement to take an equity stake in Essentia Analytics, Ltd., … Continued
Oxford BioTherapeutics (OBT), a clinical stage oncology company with a pipeline of immuno-oncology and ADC-based therapies, today announced that it has received another milestone payment from Boehringer Ingelheim (BI) for the progress of a second oncology drug candidate (BI 765049), discovered during the first phase of the partnership, into the clinic. In addition to OBT’s … Continued
Arecor announces positive headline results from first phase 1 clinical trial of AT278 ultra-rapid acting insulin candidate for diabetes. AT278 delivers significantly accelerated PK/PD profile compared to Novorapid Potential to be first concentrated (500U/mL) ultra-rapid acting insulin product enabling miniaturisation of next generation insulin delivery devices. Potential to enable more effective disease management for insulin … Continued
Calculus is delighted to announce the appointments of Matthew Moynes and Frank Spurway as Investor Relations Assistant Director and Analyst respectively. Matthew joins Calculus from Barclays Wealth where he was the Head of Venture Capital Products responsible for managing the tax efficient third-party manager panel and driving distribution through product specialist support to Wealth Managers … Continued
Hardman & Co’s latest EIS Navigator Podcast Episode, hosted by Dr Brian Moretta FFA, featured Calculus Capital CEO John Glencross on the topic of “long term perspective on EIS and VCT investing”. You can listen below.
Brouhaha Entertainment was founded by experienced producers: Oscar nominated Gabrielle Tana, Independent film industry pioneer Troy Lum and producer Andrew Mason Founders have successfully produced 27 films and 9 television projects to date, featuring top talent from around the globe Investment will be used to expand the team and fund development in film and particularly … Continued